Recent studies have shown that IL6 activates STAT3 which regulates transcription of phosphatase of regenerating liver-3 (PRL-3), and that upregulation of PRL-3 increases MM cell viability and re-phosphorylates STAT3 through direct interaction and deactivation of SHP2. Here, IL6 is linked to Miyoshi myopathy.